Inspire(US:INSP) Globenewswire·2025-12-11 21:32Core Viewpoint - Inspire Medical Systems, Inc. is facing allegations of misleading investors regarding the launch of its new product, Inspire V, which reportedly failed due to poor demand and inadequate preparations [3][4]. Group 1: Allegations and Issues - The class period for the allegations is from August 6, 2024, to August 4, 2025 [3]. - The complaint states that the launch of Inspire V was a disaster, with significant surplus inventory and reluctance from providers to transition to the new treatment [3]. - Defendants allegedly made false statements about the successful launch, while failing to complete essential tasks such as training for treatment center customers and setting up necessary IT systems [3][4]. Group 2: Shareholder Actions - Shareholders who purchased INSP shares during the class period are encouraged to register for potential lead plaintiff appointment, with a deadline of January 5, 2026 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Group 3: Legal Representation - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to recover losses incurred by investors due to misleading statements or omissions that led to artificial inflation of the company's stock [5].